$NULF NuLife Sciences Inc. is a biomedical company focused on medical research and technology that has the potential to address significant unmet medical needs in applications including wound care, organ and tissue transplants, regenerative medicine, and cell therapy. NuLife Sciences Inc. operates through two wholly-owned subsidiaries, NuLife Medical and NuLife BioMed. NuLife Medical utilizes a patent protected and unique proprietary method referred to as the "NuLife Technique" for the treatment of chronic wounds that resist closure or healing, such as diabetic foot ulcers and abrasions. NuLife Medical is currently applying the treatment to trial patients in Latin America with the goal of expanding globally, and into the United States. NuLife BioMed focuses on advancing human organ transplant technology that could potentially eliminate the need for an organ or tissue match and the necessity for anti-rejection drugs. NuLife BioMed utilizes the NuLife Technique and is currently in preclinical trials involving animal studies on its pathway to commercialization. The Company also seeks opportunities to acquire, merge or develop with other technologies with a focus on changing and saving lives. For more information please visit www.nulifesciences.us.

http://www.nulifesciences.us/